Press release "Cambridge Healthcare & Biotech add pricing and market access experts, RJW & Partners to list of alliance partners" March 2009

Article "Licensing to big pharma – virtues and vices" Life Science Clusters, Spring 2009

"Company attitudes to Hanley Grange" A survey of high technology companies based at Granta Park, Babraham Research Campus, Chesterford Research Park and in the immediate vicinity of the proposed development, plus associated press release, June 2008

"License or Buy? Current Trends in the Biotech Sector and Recommended Strategic Options", MBE Dissertation, Gigi Wong, plus associated press release, "Acquisitions of UK biotech companies overtake licensing deals for the first time in 2007", June 2008

Biotech Britain, a roundtable discussion on the current state of the UK biotech sector organised by Pfizer and the New Statesman magazine, May 2008

"Maximising Malaysia’s Role in the Global Biopharmaceutical Value Chain", Martyn Postle's presentation at EU-Malaysia Biotechnology Business Partnership in Kuala Lumpur, October 2007

"The Biotech Supremacy", CH&B article on UK biotech in Pharmaceutical Executive Europe, October 2007

"The UK Drug Pipeline: A Leader in Drug Innovation", Martyn Postle's presentation at BIO2007 in Boston, plus associated press release giving details of our report, May 2007

"Sarah Brereton joins Cambridge Healthcare & Biotech as Marketing & Administration Manager", Press Release, January 2007

"The valuation of part-developed projects in the pharmaceutical sector", MBE dissertation, Sangeeta Puran, June 2005

"Somethings Gotta Give: Possible M&A and Commercialisation Trends in Life Science from 2005 onward", Continuing the series of "two hander" articles and presentations, Dave Schulman and Martyn Postle jointly authored this article which also appeared in the Thompson Financial Directory of M&A Intermediaries

"Marketing & Development Issues; What is Each Party Looking For?", a presentation by Dave Schulman of Dechert and Martyn Postle given at the BioPharm Licensing conference, November 2004

"CH&B appointed as overall project manager for a series of biotechnology audits in the East of England", Press release, April 2004

"Survey of out-licensing biotech companies reveals Bristol-Myers Squibb perceived to be the best company to deal with, Abbott perceived to be the worst", Press release, November 2003

"The Biotech Funding Crisis: Cutting the Gordian Knot", Article by Dave Schulman of Dechert and Martyn Postle looking at novel funding options for biotech companies, published in Biotechnology Investment Today, Vol.2 Issue 2 Summer 2003

"For the merely large, it's back to basics", Martyn Postle has authored an article commenting on the potential impact of giant pharma companies in the August 2003 edition of PharmaVOICE

"Steve Tomlin joins Cambridge Healthcare & Biotech as a Principal Associate", Press release, August 2003

"Cambridge Healthcare & Biotech Ltd tonight announced the formation of a new consulting company", Press release, March 2003